Literature DB >> 17720042

Systemic inflammation and skeletal muscle dysfunction in chronic obstructive pulmonary disease: state of the art and novel insights in regulation of muscle plasticity.

Alexander H Remels1, Harry R Gosker, Jos van der Velden, Ramon C Langen, Annemie M Schols.   

Abstract

Systemic inflammation is a recognized hallmark of chronic obstructive pulmonary disease pathogenesis. Although the origin and mechanisms responsible for the persistent chronic inflammatory process remain to be elucidated, it is recognized that it plays an important role in skeletal muscle pathology as observed in chronic obstructive pulmonary disease and several other chronic inflammatory disorders. This article describes state-of-the-art knowledge and novel insights in the role of inflammatory processes on several aspects of inflammation-related skeletal muscle pathology and offers new insights in therapeutic perspectives.

Entities:  

Mesh:

Year:  2007        PMID: 17720042     DOI: 10.1016/j.ccm.2007.06.003

Source DB:  PubMed          Journal:  Clin Chest Med        ISSN: 0272-5231            Impact factor:   2.878


  13 in total

1.  Lack of caspase-3 attenuates immobilization-induced muscle atrophy and loss of tension generation along with mitigation of apoptosis and inflammation.

Authors:  Shimei Zhu; Michio Nagashima; Mohammed A S Khan; Shingo Yasuhara; Masao Kaneki; J A Jeevendra Martyn
Journal:  Muscle Nerve       Date:  2013-02-09       Impact factor: 3.217

2.  Cachexia and aging: an update based on the Fourth International Cachexia Meeting.

Authors:  J E Morley; S D Anker; W J Evans
Journal:  J Nutr Health Aging       Date:  2009-01       Impact factor: 4.075

3.  Lipid-soluble components in cigarette smoke induce mitochondrial production of reactive oxygen species in lung epithelial cells.

Authors:  Marco van der Toorn; Delaram Rezayat; Henk F Kauffman; Stephan J L Bakker; Rijk O B Gans; Gerard H Koëter; Augustine M K Choi; Antoon J M van Oosterhout; Dirk-Jan Slebos
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-05-01       Impact factor: 5.464

4.  Adenosine A2B Receptors - Mediated Induction of Interleukin-6 in Skeletal Muscle Cells.

Authors:  Mansour Haddad
Journal:  Turk J Pharm Sci       Date:  2017-04-15

5.  Adjunctive Treatment with Rhodiola Crenulata in Patients with Chronic Obstructive Pulmonary Disease--A Randomized Placebo Controlled Double Blind Clinical Trial.

Authors:  Ming-Lung Chuang; Tzu-Chin Wu; Yau-Tung Wang; Yau-Chen Wang; Thomas C-Y Tsao; James Cheng-Chung Wei; Chia-Yin Chen; I-Feng Lin
Journal:  PLoS One       Date:  2015-06-22       Impact factor: 3.240

6.  Prediction of key genes and miRNAs responsible for loss of muscle force in patients during an acute exacerbation of chronic obstructive pulmonary disease.

Authors:  Yanhong Duan; Min Zhou; Jian Xiao; Chaomin Wu; Lei Zhou; Feng Zhou; Chunling Du; Yuanlin Song
Journal:  Int J Mol Med       Date:  2016-09-30       Impact factor: 4.101

7.  Sarcopenia as an Independent Risk Factor for Decreased BMD in COPD Patients: Korean National Health and Nutrition Examination Surveys IV and V (2008-2011).

Authors:  Dong-Won Lee; Eun-Young Choi
Journal:  PLoS One       Date:  2016-10-17       Impact factor: 3.240

8.  The effects of exercise and conjugated linoleic acid intake on IGF-1 and pro-inflammatory cytokines in atrophied skeletal muscle of rats.

Authors:  Sanghyun Kim; Kijin Kim
Journal:  Integr Med Res       Date:  2013-10-01

9.  Factors associated with appendicular skeletal muscle mass among male Chinese patients with stable chronic obstructive pulmonary disease: A hospital-based cross-sectional study.

Authors:  Yanxia Han; Zhenyun Wu; Yi Chen; Yanan Kan; Min Geng; Nuo Xu; Hongying Qian; Hai Fang Wang; Meie Niu
Journal:  Medicine (Baltimore)       Date:  2019-10       Impact factor: 1.889

10.  Endoribonuclease L (RNase L) regulates the myogenic and adipogenic potential of myogenic cells.

Authors:  Tamim Salehzada; Linda Cambier; Nga Vu Thi; Laurent Manchon; Laëtitia Regnier; Catherine Bisbal
Journal:  PLoS One       Date:  2009-10-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.